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Abstract
Mutations in the gene encoding the microtubule severing ATPase spastin are the most frequent cause of hereditary spastic 
paraplegia, a genetic condition characterised by length-dependent axonal degeneration. Here, we show that HeLa cells lack-
ing spastin and embryonic fibroblasts from a spastin knock-in mouse model become highly polarised and develop cellular 
protrusions. In HeLa cells, this phenotype was rescued by wild-type spastin, but not by forms unable to sever microtubules 
or interact with endosomal ESCRT-III proteins. Cells lacking the spastin-interacting ESCRT-III-associated proteins IST1 or 
CHMP1B also developed protrusions. The protrusion phenotype required protrudin, a RAB-interacting protein that interacts 
with spastin and localises to ER–endosome contact sites, where it promotes KIF5-dependent endosomal motility to protru-
sions. Consistent with this, the protrusion phenotype in cells lacking spastin also required KIF5. Lack or mutation of spastin 
resulted in functional consequences for receptor traffic of a pathway implicated in HSP, as Bone Morphogenetic Protein 
receptor distribution became polarised. Our results, therefore, identify a novel role for ESCRT-III proteins and spastin in 
regulating polarised membrane traffic.
Keywords Protrusion formation · AAA ATPase · Axonopathy · Bone morphogenetic protein signalling · Microtubule 
modification
Introduction
The hereditary spastic paraplegias (HSPs) are genetic con-
ditions in which there is distal degeneration of the longest 
axons of the corticospinal tract, the main central nervous 
system pathway that connects the motor cerebral cortex to 
the spinal cord [1]. This causes HSP patients to develop 
progressive and disabling lower limb weakness and stiffness. 
Mutations in more than 70 genes that cause HSP have been 
identified, and analysis of the proteins encoded by these 
genes has revealed that they function in a relatively small 
number of cellular processes, prominent amongst which is 
membrane traffic [2, 3].
The function of spastin is particularly important in under-
standing the pathogenesis of HSP, as mutations in SPAST/
SPG4, the gene encoding it, are by far the most common 
cause of the condition in northern Europe and North Amer-
ica [4]. Spastin is a microtubule severing ATPase enzyme, 
which oligomerises as a hexamer before using the energy 
provided by ATP hydrolysis to create internal breaks or 
nanoscale damage (“nicks”) in microtubules [5, 6]. The 
SPAST mutational spectrum in HSP includes nonsense, 
frameshift, splicing and exon/whole gene deletion muta-
tions, indicating that in most cases the molecular patho-
logical mechanism is haploinsufficiency [7–11]. Missense 
mutations affecting the ATPase domain are also commonly 
found. These have been reported to affect ATP binding, ATP 
hydrolysis or oligomerisation of the protein, and so these 
mutations also likely cause loss of spastin function [12], 
although it is possible that mutations affecting ATP binding 
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or hydrolysis could exert a dominant negative effect on the 
spastin hexamer, perhaps blocking the ATPase cycle at a 
point where spastin is bound to microtubules [13].
We showed recently that spastin participates in molecu-
lar machinery at ER–endosome contacts that drives fission 
of endosomal tubules. These tubules arise from endosomal 
compartments and are involved in recycling and retrieval of 
receptors, such as the transferrin receptor (TfnR) or mannose 
6-phosphate receptors (M6PRs), back to the plasma mem-
brane (directly, or indirectly via the perinuclear recycling 
compartment) or to the Golgi apparatus [14]. Formation, 
breakage and transport of these tubules occur along micro-
tubules and require microtubule-dependent motors, such as 
kinesins (for plus-end-directed transport) and dynein (for 
minus-end-directed transport) [15, 16]. Proteins that are not 
sorted away from endosomes via these and other pathways 
are trafficked to the late endosomal/lysosomal pathway for 
degradation [14]. Spastin localises to contacts between the 
ER and endosome that are sites of endosomal tubule fis-
sion. These contacts involve an interaction between an ER-
localised isoform of spastin (M1-spastin) and the endosomal 
protein IST1, an atypical member of the ESCRT-III (endoso-
mal sorting complex required for transport-III) complex [15, 
17]. Spastin is required for efficient tubule fission, so that 
TfnRs and M6PRs are retained in the endo-lysosomal path-
way in cells lacking spastin. Spastin requires its ATPase and 
ESCRT-interacting functions to promote endosomal tubule 
fission [15, 17].
The location of spastin at ER–endosome contacts paral-
lels that of another spastin interactor, protrudin/ZFYVE27. 
Protrudin was first characterised as a driver of polarised 
membrane traffic. HeLa cells expressing protrudin develop 
long microtubule-based cellular protrusions, while protru-
din promoted neurite extension in rat hippocampal neurons 
and PC12 cells. In PC12 cells, NGF treatment resulted in 
movement of protrudin from its predominant steady-state 
localization in the ER to what was described as a RAB11-
positive endosomal compartment at the tip of neurite exten-
sions [18]; however, recent work suggests that this apparent 
redistribution to endosomes actually reflects increased con-
tact between this organelle and ER-localised protrudin [19].
Two mechanisms have been proposed for how protrudin 
drives cellular protrusion formation. Protrudin contains a 
RAB-binding domain (RBD) that preferentially binds to 
RAB11-GDP, which it locks in this inactive state. This bind-
ing is enhanced by ERK-driven protrudin phosphorylation 
that occurs downstream of NGF treatment. Thus, it has been 
proposed that protrudin inhibits RAB11-dependent general-
ised (i.e., non-polarised) endosomal recycling [18]. In addi-
tion, protrudin has functional and physical interactions with 
kinesin motor KIF5 proteins. Protrudin interacts with KIF5A 
(a neuron-specific kinesin) in brain tissue, protrudin colocal-
ises with KIF5 and RAB11 in the cell body and protrusions 
of HeLa cells expressing protrudin, expression of KIF5A 
in HeLa cells promotes protrusion formation, while deple-
tion of KIF5B (the endogenous KIF5 present in HeLa cells) 
reduces the protrusion phenotype seen on protrudin expres-
sion [20, 21]. More recently, protrudin has been shown to 
bind late endosomal RAB7 at ER–endosome contact points, 
where it promotes transfer of KIF5 to the endosomal motor 
protein adaptor FYCO1, to promote polarised traffic of 
late endosomes [19]. Considered together, these observa-
tions suggest a model where increased association between 
protrudin and endosomal RAB proteins at ER–endosome 
contact sites drives polarised membrane traffic by switch-
ing off RAB11-GTP-dependent generalised endosomal recy-
cling, and promoting KIF5-dependent polarised traffic into 
protrusions.
In light of its interaction with protrudin, we hypothesised 
that spastin might also function in polarised membrane traf-
fic. Here, we show that primary cells from a spastin mouse 
knocked in for a disease-associated ATPase mutation and 
HeLa cells lacking spastin become highly polarised, with 
the development of long cellular protrusions that require 
protrudin and KIF5 for their development. This polarisa-
tion phenotype could be rescued by wild-type spastin, but 
not by a form unable to bind to ESCRT-III. Consistent with 
this, cells lacking the ESCRT-III proteins that bind spas-
tin also developed protrusions. The polarisation phenotype 
had functional consequences for receptor traffic, as HeLa 
cells lacking spastin and cells from the knock-in mouse had 
altered plasma membrane distribution of Bone Morpho-
genetic Protein signalling receptors, a pathway implicated 
in HSP. Thus, considered with our previous work showing 
that spastin promotes generalised endosomal recycling, 
our results indicate that microtubule modelling by spastin 
regulates the balance between generalised and protrudin-
dependent polarised endosomal membrane traffic.
Materials and methods
Antibodies
Rabbit polyclonal anti-spastin (86-340) was produced as 
previously described [23]. Mouse monoclonal anti-spas-
tin (6C6) and mouse monoclonal anti-Acetylated tubu-
lin (6-11B-1) were obtained from Sigma-Aldrich. Mouse 
monoclonal anti-myc (4A6) was obtained from Millipore. 
Rabbit polyclonal anti-myc tag (ab9106), rabbit anti-GFP 
(ab6556) and rat anti-alpha-tubulin-tyrosinated clone 
YL12/2 (ab6160) were obtained from Abcam. Rat anti-RFP 
(5F8) was obtained from Chromotek. Goat anti-BMPR2 
(EB08820) and goat anti-Kinesin-1/KIF5 (EB05492) were 
obtained from Everest Biotech. Rabbit polyclonal anti-
ZFYVE27 (12680-1AP) and anti-IST1 (51002-1-AP) were 
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obtained from Proteintech. Mouse monoclonal anti-TfnR 
(13-6800) was obtained from Invitrogen. Rabbit polyclonal 
anti-GAPDH (2118) was obtained from Cell Signaling Tech-
nology. Rabbit polyclonal anti-CHMP1B was produced as 
previously described [15]. Peroxidase conjugated secondary 
antibodies for western blotting were obtained from Sigma-
Aldrich. Alexafluor-labelled secondary antibodies for immu-
nofluorescence were obtained from Molecular Probes.
Constructs and generation of stable cell lines
pLXIN-myc-Spastin M1 wild-type (wt) and M87 wt, K388R 
and F124D constructs for generation of stable cell lines were 
made as previously described [15]. Briefly M87 or M87A-
M1 Spastin was cloned into pIRESneo2 (Clontech) fol-
lowed by insertion of a myc tag (mutagenesis of the M87 
residue ensures that no M87 transcript is produced from the 
M1 construct). Myc-spastin was further cloned into SalI-
BamHI sites in pLXIN. pLXIN-myc-M87-Spastin-K388R 
and F124D mutants were then generated and all constructs 
were made resistant to spastin siRNA 1 and 3 by introducing 
two mutations into each of the relevant sequences by site-
directed mutagenesis. Myc-BMRP2 stable cell lines were 
generated by PCR of the myc-BMRP2 construct described 
in [22] and cloning the myc-BMPR2 fragment into pLXIN, 
followed by retroviral transduction of HeLa cells.
Cell culture, transfection and siRNAs
HelaM and MRC5 cells were maintained as previously 
described [23]. HeLaM cells stably expressing spastin 
constructs were additionally cultured in the presence of 
500 μg/ml Geneticin (Invitrogen). Mouse embryonic fibro-
blasts (MEFs) were obtained from E14 mouse embryos and 
cultured in DMEM containing 10% foetal calf serum, 1% 
penicillin–streptomycin (Invitrogen), 1% l-glutamine (Invit-
rogen), 1% MEM non-essential amino acids (Invitrogen) and 
0.1% 2-mercaptoethanol (Invitrogen). For transient transfec-
tions of plasmid DNA, HeLaM cells were transfected using 
Effectine (Qiagen) following the manufacturer’s protocol, 
and incubated for 24 h before analysis. For siRNA transfec-
tion, cells were transfected with the relevant siRNAs, using 
Oligofectamine transfection reagent (Invitrogen), according 
to a 5-day protocol modified from [24]. Briefly, HeLaM or 
MRC5 cells were plated into a well of a 6-well plate and 
transfected with siRNA after 24 h. Cells were harvested 
96 h later. The efficiency of siRNA knock-down was veri-
fied by immunoblotting cell lysates and/or by immunofluo-
rescence microscopy of fixed cells, with an antibody against 
the relevant protein, or in the case of some protrudin deple-
tion experiments (performed when an endogenous protru-
din antibody was not available), by carrying out parallel 
knock-down experiments in cells transiently expressing 
GFP-protrudin and validating protein knock-down using an 
anti-GFP antibody for immunoblotting. The following siR-
NAs were obtained from Dharmacon and used at the indi-
cated concentrations:
Spastin (5 nM), siRNA1: 5′-GAA CUU CAA CCU UCU 
AUA A, siRNA3: 5′-UAU AAG UGC UGC AAG UUU A.
Protrudin (20 nm), siRNA3: 5′-GUA ACC AGA CCU UGA 
GCA A; siRNA4: 5′-ACA AGA GGC UGG AGA UCU A.
KIF5B (10 nm) siRNA1: 5′-GCA GUC AGG UCA AAG 
AAU A; siRNA custom2: 5′-UGA AUU GCU UAG UGA 
UGA AUUUU.
IST1 (25 nM), siRNA1: 5′-CCA AGU AUA GCA AGG 
AAU A-3′ (D-020977-01); siRNA3, 5′-GCA AAU ACG 
CCU UUC UCA U-3′ (D-020977-03).
CHMP1B (10  nM), siRNA: 5′-GAA GAU UUC UGC 
UUU GAU GUU-3′ (D-004698-01); siRNA6: 5′-GUC 
GAU GGC UGG UGU GGU U-3′ (J-004698-06); siRNA7: 
5′-CCU UCG GGA UCA AGU GUG A-3′ (J-004698-07).
Immunofluorescence microscopy of HeLa cells 
and MEFs
For immunofluorescence co-localisation cells were either 
fixed at room temperature in 3.7% (v/v) formaldehyde in 
phosphate-buffered saline (PBS) and permeabilised in PBS 
containing 0.1% (v/v) Triton-X100 (Sigma) or fixed and per-
meabilised for 5 min with ice-cold Methanol (Fisher Sci-
entific). Where pre-fixation extraction of cytosolic protein 
was required, this was carried out using a saponin-based 
extraction buffer as previously described [25]. Fixed cells 
on coverslips were blocked in 5% foetal calf serum in PBS 
for 1 h and incubated with primary antibodies and Alexa 
 Fluor® conjugated secondary antibodies in blocking buffer 
and mounted onto glass slides using  Prolong® Gold antifade 
reagent with DAPI (Molecular Probes). Cells were visual-
ised using a Zeiss LSM880 confocal microscope using a 
63 × oil immersion objective and images captured using Zen 
software. To quantify the degree of co-localisation between 
individual pixels in different fluorescent channels, a Pear-
son’s correlation coefficient with Costes automatic thresh-
olding was calculated using Volocity Software (Quorum 
Technologies) for individual cells in each image. Images 
of SNX1 immunofluorescence (i.e., for endosomal tubule 
quantification) were obtained with a Zeiss AxioImager Z2 
Motorized Upright Microscope (63 × NA 1.40 oil immer-
sion objective, room temperature, Zeiss Axiocam 506) and 
deconvolved with Huygens Professional version 18.04 (Sci-
entific Volume Imaging, The Netherlands, http://svi.nl). 
Images were subsequently processed using Adobe Photo-
shop and presented using Adobe Illustrator.
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Protrusion quantification in HeLa Cells and MEFS
HelaM cells were plated at low density (1 × 104) onto 
poly-d-lysine (Sigma-Aldrich)-coated coverslips in six-
well plates. 24 h later, cells were transfected with spastin 
siRNA with or without rescue siRNA oligonucleotides 
and incubated for a further 96 h. Cells were then fixed and 
permeabilised in ice-cold methanol and labelled with anti-
acetylated tubulin primary antibodies and Alexa  Fluor® 
conjugated secondary antibodies. Coverslips were mounted 
onto glass slides using  Prolong® Gold antifade reagent with 
DAPI (Molecular Probes) and cells were visualised using a 
Zeiss Axioimager Z2 Wide-field upright microscope with 
a motorised stage and 40 × oil immersion objective. Some 
images were deconvolved as above. Stitched images of 5 × 5 
individual tiles were automatically captured using Zen Pro 
analysis software and cells in 25 automatically captured 
fields were analysed per coverslip. Protrusions were defined 
as cell extensions which were acetylated tubulin positive 
with a length greater than 2 × the widest diameter of the 
nucleus, a stringent criterion compared to previous publica-
tions that have used a process length greater than 1 × the 
nuclear diameter [26]. In cells with more than one protru-
sion, the longest protrusion only was counted. The length 
of each protrusion was manually measured using the spline 
curve tool in Zen from the edge of the nucleus to the longest 
point away from the nucleus identified by acetylated tubulin 
immunofluorescence. The total number of cells in 25 fields 
per coverslip was then automatically counted using a nucleus 
detection protocol or using cellular detection with a whole 
cell stain (Thermo Scientific) in Zen and the percentage of 
total cells with protrusions was calculated. For each inde-
pendent experiment, between 300 and 1000 cells were ana-
lysed per siRNA and at least three independent experiments 
were carried out. For quantification of protrusions in MEFs, 
the same protocol and measurement parameters were used 
and in addition protrusions were only counted if the diameter 
of the half way point along the length of each protrusion was 
equal to or less than 10 µm.
Protrusion rescue experiments in stable cell lines
For protrusion rescue experiments in myc-spastin stable 
cell lines, Zen Pro analysis software was first used to set a 
fluorescence intensity threshold in the fluorescent channel 
of the myc tag to identify the total number of stably trans-
fected cells in 25 fields. Protrusions were then counted in 
all cells identified as stably transfected and the number of 
stable expressing cells with protrusions was expressed as a 
percentage of the total.
Western blotting
Cells were washed twice with PBS and lysed in ice-cold 
lysis buffer (25 mM HEPES pH 7.4, 1 mM EDTA, 150 mM 
NaCl, 0.5% TX100, protease inhibitors). Lysate was centri-
fuged at 13,000 rpm for 15 min and protein concentration 
in the supernatant was quantified using BCA protein assay 
(Pierce). 30 µg of protein was resolved using SDS-PAGE and 
protein gels were blotted onto Nitrocellulose membrane and 
blocked in 5% non-fat dried milk in TBS-Tween. Membrane 
was incubated with primary antibodies and HRP-conjugated 
secondary antibodies in blocking buffer and HRP-signal 
detected with SuperSignal ® West Pico Chemiluminescent 
Substrate using X-Ray film (Fuji Medical).
Statistical analysis
Statistical analysis was performed using unpaired two-
tailed Student’s t tests or one-way ANOVA with Dunnett’s 
or Tukey’s post hoc tests for multiple comparisons, using 
GraphPad Prism 5.01 for Windows (GraphPad Software, San 
Diego) statistical software. Bars in all histograms represent 
mean ± standard error of the mean; bars in dot plot represent 
mean ± standard deviation.
Animals
Mice were maintained in accordance with UK and European 
Union regulations. Animal work for this study was approved 
by the University of Cambridge Ethical Review Commit-
tee and was performed under project licenses (80/2304 and 
70/7888) granted by the UK Home Office under the Animals 
(Scientific Procedures) Act 1986. The University of Cam-
bridge is a designated establishment for breeding and scien-
tific procedures under the Animals (Scientific Procedures) 
Act 1986. Spastin knock-in mice were housed, maintained 
Fig. 1  Functional spastin is required to prevent protrusion forma-
tion. a MEFs from mice with the genotypes indicated were fixed 
and labelled for acetylated tubulin, and the percentage of cells with 
protrusions plotted in b. n = at least 5 biological repeats for each 
genotype. c HeLa cells were mock-transfected, or transfected with 
the siRNAs indicated, then labelled for acetylated tubulin. The lower 
panels show higher magnification views of the boxed areas in the 
upper panels. The percentage of cells with protrusions is quantified 
in d, n = 6 biological repeats. e Spastin depletion in these experiments 
was validated by immunoblotting. f HeLa cells were mock-transfected 
or subject to spastin knock-down (KD) and labelled with antibodies 
to tyrosinated or acetylated tubulin. g Mock-transfected HeLa cells 
or HeLa cells transfected with the siRNAs indicated were lysed and 
immunoblotted for the antibodies shown. h HeLa cells depleted for 
spastin were transfected for RAB11-GFP and labelled for acetylated 
tubulin. RAB11 accumulates at the tip of protrusions. The right panel 
shows a magnified view of the boxed area in the left-hand panel. In 
e and g, GAPDH blotting serves to validate equal protein loading. P 
values were generated by one-way ANOVA with Dunnett’s post hoc 
test for multiple comparisons, histograms in this and all subsequent 
figures show mean ± SEM. Scale bars = 20 μm
◂
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on a C57BL/6J background and bred to generate embryos by 
heterozygous breeding as previously described [27].
Results
Embryonic fibroblasts from a spastin 
ATPase‑defective knock‑in mouse model develop 
protrusions
We began by examining the morphology of murine embry-
onic fibroblasts (MEFs) derived from a spastin mouse model 
 (spastinN386K) knocked in for an HSP-associated mutation 
that renders the protein ATPase deficient and unable to sever 
microtubules. These mice express mutant spastin at endog-
enous levels and so results are physiologically relevant. In 
addition, homozygous mutant mice develop a gait phenotype 
consistent with human HSP and cultured primary neurons 
from these mice show pathological axonal swellings; thus, 
these mice appear to be an excellent HSP disease model 
[17, 27].
We found a significant increase in cellular protrusions in 
MEFs derived from  spastinN384K/N384K mice versus controls 
(Fig. 1a, b). The protrusions were filled with linear arrays 
of microtubules and were defined as cell extensions which 
were tubulin positive and with a length greater than 2 × the 
diameter of the nucleus of the cell from which it arose.
We validated the relevance of these findings to humans 
using HeLa cells, a line that has already been shown to gen-
erate protrudin-dependent protrusions [19]. Using two dif-
ferent siRNA oligonucleotides, we saw a highly significant 
increase in the proportion of cells with protrusions in cells 
lacking spastin (Fig. 1c–e). These protrusions were typically 
many times longer than the diameter of the cell body from 
which they originated (> 60% were longer than 80 μm, i.e., 
representing 4 × the typical nuclear diameter) and were filled 
with a linear array of microtubules (Fig. 1c). The microtu-
bules were labelled strongly with antibodies for tyrosinated 
tubulin, an indicator of dynamic microtubules that are prone 
to growth and shrinkage, and especially for acetylated tubu-
lin, an indicator of long-lived structures that are associated 
with long-range transport (Fig. 1f) [28]. These tubulin modi-
fications in protrusions were not associated with alterations 
in total cellular content of acetylated or tyrosinated tubulin, 
as measured by immunoblotting (Fig. 1g). The protrusions 
were also clearly visible upon cellular labelling with a whole 
cell stain or with the actin marker phalloidin (Supplemen-
tary Figure 1). Markers of endosomes accumulated at pro-
trusion tips, including RAB11 (which was present in every 
protrusion where it was analysed) (Fig. 1h) and transferrin 
receptor, as well as SNX1 (a marker of endosomal tubules) 
and RAB5 and 7 (early and late endosomal markers, respec-
tively; not shown). We also observed protrusion formation 
when spastin was depleted from MRC5 cells, a human 
fibroblast line, confirming the relevance of this phenotype 
to cells from at least two human germ layers (Supplementary 
Figure 1).
We concluded that spastin inhibits protrusion formation 
in mice and humans, and that this requires its ATPase activ-
ity, and hence its ability to modify microtubules.
ESCRT interaction as well as ATPase activity 
is required for spastin to regulate polarised 
membrane traffic in human cells
To analyse further the functional requirements for spastin to 
prevent protrusion formation, we carried out siRNA-rescue 
experiments in HeLa cell lines stably expressing siRNA-
resistant forms of human spastin.
Mammalian cell types express at least two spastin iso-
forms, a less-abundant full-length form (M1-spastin) and 
a more highly expressed isoform (M87-spastin) that lacks 
the N-terminal 86 amino acids of the full-length protein 
(Fig. 2a) [29]. M1-spastin localises to the ER via a predicted 
hairpin membrane domain that is specific to this isoform 
[23, 30]. Here, it participates with the endosomal ESCRT-III 
protein IST1 in ER–endosome contacts that promote endo-
somal tubule fission [17]. This M1 isoform (but not the M87 
isoform) interacts with protrudin and several ER-resident 
proteins that have been implicated in HSP, very likely via 
hairpin membrane domain interactions [30–34]. Although 
M87-spastin is predominantly cytosolic at steady state, it can 
also be recruited to endosomes (and presumably ER–endo-
some contact sites) by ESCRT-III interactions [23, 35].
SiRNA-rescue experiments in HeLa cells have shown 
that either isoform is sufficient to rescue endosomal tubule 
fission defects in cells lacking endogenous spastin [15, 17]. 
Consistent with this, the cellular protrusion phenotype was 
rescued by either M1- or M87-spastin (Fig. 2b–d, g, h). In 
contrast, and consistent with the MEF data above, a form of 
M87-spastin containing the ATPase-deficient disease-asso-
ciated mutant K388R was unable to rescue the protrusion 
phenotype (Fig. 2a, e, g, h). This mutant is able to bind but 
not hydrolyse ATP and so is unable to modify microtubules, 
nor is it able to promote efficient endosomal tubule fission 
[13, 15]. Spastin binds to ESCRT-III-associated proteins 
via interactions with its microtubule interacting and traf-
ficking (MIT) domain (Fig. 2a), and introduction of the MIT 
F124D mutation, which both blocks these interactions and 
fails to support endosomal tubule fission, similarly caused 
failure to rescue protrusion formation (Fig.  2f–h) [36]. 
Finally, a form of M87 spastin lacking a region that is nec-
essary and sufficient for microtubule binding (myc-M87-
spastin∆MTB, Fig. 2a) was also unable to rescue protrusion 
formation (Fig. 2i–m) [37]. We concluded that either spastin 
isoform is sufficient to inhibit protrusion formation, although 
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Fig. 2  Functional MIT, MTB and ATPase domains are required for 
spastin to regulate protrusions. a Schematic diagram of the M1 and 
M87 isoforms of spastin. HR hydrophobic region (hairpin membrane 
domain required for ER localisation), MIT microtubule interacting 
and trafficking domain (required for ESCRT-III interaction), MTB 
microtubule binding domain, ATPase ATPase domain. The approxi-
mate position of the F124D and K388R mutations used in this study 
is indicated. b–h Wild-type HeLa cells or HeLa cells stably express-
ing the siRNA resistant constructs indicated were mock-transfected 
or transfected with siRNA targeting endogenous spastin, then fixed 
and labelled for acetylated tubulin. The percentage of cells devel-
oping cellular protrusions was then counted and plotted in g, n = a 
minimum of three biological repeats for each experimental condi-
tion. Spastin depletion and exogenous spastin expression was vali-
dated by immunoblotting (h). Note that M1 spastin is present, but in 
low abundance, in HeLa cells. i–m Wild-type HeLa cells or HeLa 
cells stably expressing the siRNA resistant constructs indicated were 
mock-transfected or transfected with siRNA targeting endogenous 
spastin, then fixed and labelled for acetylated tubulin. The percentage 
of cells developing cellular protrusions was then counted and plotted 
in l, n = 6 biological repeats. Spastin depletion and exogenous spastin 
expression was validated by immunoblotting (m). P values were gen-
erated by one-way ANOVA with Tukey’s post hoc test for multiple 
comparisons
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neither was specifically necessary, and that this property of 
spastin requires its ability to bind microtubules, hydrolyse 
ATP (and so modify microtubules), and to interact with 
ESCRT-III. Thus, the properties of spastin that are required 
to prevent protrusions are the same as those previously iden-
tified as being required for it to promote endosomal tubule 
fission [15, 17].
Spastin‑binding ESCRT‑III‑associated proteins 
inhibit protrusion formation
The spastin MIT domain is able to interact with two ESCRT-
III-associated proteins, IST1 and CHMP1B [35, 36, 38]. 
As spastin required the capacity to interact with ESCRT-
III to suppress protrusion formation, we tested the effect 
of cellular depletion of these proteins and found that lack 
of either protein caused cellular protrusions to develop 
(Fig. 3a–c).
We showed previously that IST1 is involved with spas-
tin in regulation of endosomal tubule fission [15, 17]. This 
caused cells lacking IST1 to develop increased numbers of 
SNX1-positive endosomal tubules. As IST1 and CHMP1B 
have been proposed to act together as a tubule fission 
machinery, somewhat surprisingly in this previous work, 
we found no significant effect of CHMP1B depletion on 
endosomal tubule numbers [39]. We revisited this using a 
more sensitive assay, reporting the percentage of cells with 
at least one long endosomal tubule, and found that cells lack-
ing CHMP1B also showed an increase in endosomal tubu-
lation (Supplementary Figure 2). Thus, the effects of spas-
tin, IST1 and CHMP1B depletion in inhibiting endosomal 
Fig. 2  (continued)
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tubule fission mirror their effects on inhibiting protrusion 
formation.
Protrusion formation in cells lacking spastin 
requires protrudin and KIF5A
We examined whether the protrusions seen in cells lacking 
spastin were generated by the protrudin-KIF5-dependent 
mechanism proposed by Raiborg et al. [19]. We began by 
examining whether the subcellular localization of protru-
din and KIF5 was affected by spastin depletion. Protrudin 
and KIF5 were both present in protrusions that developed 
in HeLa cells lacking spastin (Fig. 4a; Supplementary Fig-
ure 3). KIF5 and protrudin showed minimal co-localisation 
in wild-type cells, but punctate co-localisation was observed 
in cells lacking spastin (Fig. 4a, b; Supplementary Figure 3). 
Co-localised KIF5 and protrudin puncta were often arranged 
in linear arrays within the protrusions, probably representing 
Fig. 3  IST1 and CHMP1B prevent protrusion formation. a HeLa cells 
were subject to mock transfection or transfection with the siRNA 
oligonucleotides indicated, then labelled with acetylated tubulin and 
the percentage of cells showing protrusions quantified. The mean 
result of six such experiments for each protein depleted is shown in 
b. Protein depletion was validated by immunoblotting (c). The higher 
molecular weight band (asterisk) recognised by the CHMP1B anti-
body represents a non-specific cross-reaction. P values were gener-
ated by one-way ANOVA with Dunnett’s post hoc test for multiple 
comparisons. Scale bar = 20 μm
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alignment along a microtubule, and in some cases co-local-
ised with an endosomal marker (Fig. 4a, c; Supplementary 
Figure 3). Thus, spastin depletion promotes co-localisation 
of protrudin and KIF5A in cellular protrusions.
We then analysed whether protrudin or KIF5 are 
required for the protrusion formation in cells lacking spas-
tin. Using double siRNA knock down experiments in HeLa 
cells, we found that the spastin protrusion phenotype was 
efficiently rescued by concurrent knock-down of KIF5B 
or protrudin, using two independent siRNAs to target each 
transcript (Fig. 5a–c; Supplementary Figure 4).
Spastin controls the polarised traffic of membrane 
receptors implicated in HSP
Having shown that cells lacking spastin develop a polar-
ised morphology, we examined whether this affected 
polarisation of cell surface receptors. Upregulated Bone 
Morphogenetic Protein (BMP) signalling, caused by 
altered endosomal or secretory pathway trafficking of 
BMP receptors (BMPRs), has been proposed as a poten-
tial unifying mechanism in several subtypes of HSP [3, 
22]. With specific reference to spastin, zebrafish lacking 
the M1-spastin isoform have motor axonal mistargeting 
that is caused by upregulated BMP signalling [40], and 
we have shown that HeLa cells lacking the protein have 
upregulated BMP signalling, without alteration in the total 
cellular amount of the BMP receptor BMPRII [22]. We, 
therefore, examined whether this upregulated BMP signal-
ling might be associated with a more polarised distribution 
of BMP receptors.
At steady state in wild-type cells, epitope-tagged 
BMPRII is present at the plasma membrane and in early 
and recycling endosomes [22]. Consistent with this, 
in wild-type HeLa cells both endogenous BMPRII and 
Fig. 4  Increased co-localisation between protrudin, KIF5 and endo-
somal markers in cells lacking spastin. a Hela cells were transfected 
with spastin siRNA, then treated with a saponin-based buffer to wash 
out soluble cytosolic signal, before being fixed and visualised by 
immunofluorescence microscopy versus the antibodies shown. The 
lower panels show higher magnification views of the boxed areas in 
the upper panels. Large arrowheads indicate examples of co-localised 
puncta, small arrowheads indicate co-localisation of KIF5 and protru-
din along a linear structure. b, c Cells were labelled with antibodies 
to the proteins indicated, then the correlation between marker signals 
was quantified in mock-transfected cells or cells depleted of spastin 
by siRNA transfection. b n = 34 cell in each condition, c n = 10 cells 
mock and 17 cells spastin KD. Scale bar = 20 μm. P values were gen-
erated by unpaired t test
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stably expressed myc-tagged BMPRII were present at the 
plasma membrane in a non-polarised distribution, and also 
in intracellular vesicles that showed occasional alignment 
with microtubules (Fig. 6a, b). However, in cells lacking 
spastin, both endogenous and stably expressed BMPRII 
became much more polarised, with strong signal being 
present on the plasma membrane of protrusions, especially 
at their tip (Fig. 6c, d). BMPRII signal was also present 
intracellularly within the protrusions, where it aligned 
with markers of microtubules and KIF5. Although we can-
not completely exclude this overlap as being the result of 
the concentration of the markers within a confined cellular 
space, it is consistent with the idea that BMPR-containing 
endosomes are subject to KIF5-dependent microtubule-
based transport into the protrusions (Fig. 6e, f). In addi-
tion, in cells lacking spastin, there was generally increased 
Fig. 5  Protrudin and KIF5 are required for the protrusions that 
develop in cells lacking spastin. a–c HeLa cells were mock-trans-
fected, or transfected with the indicated spastin siRNAs, spastin and 
protrudin siRNAs, or spastin and KIF5B siRNAs, then labelled for 
acetylated tubulin. Selected representative images are shown in a, 
with the lower panels being higher magnification views of the boxed 
areas shown in the upper panels. The percentage of cells with pro-
trusions was quantified in b, n = at least 4 biological repeats for each 
experimental condition. Protein depletion was confirmed by immu-
noblotting (c). In these experiments, as an antibody to endogenous 
protrudin was not then available, protrudin depletion was verified by 
carrying out siRNA transfection experiments in parallel, in cells tran-
siently expressing GFP-protrudin. Anti-GFP immunoblotting of these 
cells is shown. Subsequent validation that the siRNAs used could 
deplete cells of endogenous protrudin is shown in Supplementary 
Figure 4. P values generated by one-way ANOVA with Tukey’s post 
hoc test for multiple comparisons. Scale bar = 20 μm
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colocalisation between endogenous BMPRII and protrudin 
(Supplementary Figure 5).
We confirmed the physiological relevance of these obser-
vations in MEFs from  spastinN384K/N384K mice, where we 
found that endogenous BMPRII had a highly polarised 
distribution at the tips of the protrusions that developed in 
heterozygous, and especially homozygous, knock-in mice 
(Fig. 7).
Discussion
A model for protrudin-dependent protrusion formation has 
been proposed, in which ER-localised protrudin interacts 
with late endosomes by co-incident detection of RAB7 and 
phosphatidylinositol 3-phosphate. These contacts facili-
tate transfer of KIF5 that has been captured by protrudin, 
to the late endosomal motor adaptor FYCO1. This process 
promotes microtubule-motor-dependent movement of late 
endosomes towards the plasma membrane, with which they 
fuse, thereby delivering membrane to drive protrusion for-
mation [19]. Our work now demonstrates that spastin regu-
lates this process. HeLa cells lacking spastin developed long 
protrusions that required protrudin and KIF5 for their forma-
tion. Cells lacking spastin had increased co-localisation of 
protrudin, KIF5 and endosomal markers within protrusions, 
consistent with previous observations that over-expression of 
protrudin increases its co-localisation with FYCO1-bearing 
endosomes [19]. Considered together, our results indicate 
that spastin inhibits protrudin-dependent protrusion for-
mation. This role for spastin is physiologically relevant, as 
embryonic fibroblasts from a spastin knock-in mouse model, 
which expresses at endogenous levels an ATPase-defective 
form of the protein, also became polarised and developed 
long cellular protrusions.
How could spastin antagonise the function of protru-
din? Spastin promotes endosomal tubule fission of SNX1 
and SNX4 tubules, and the functional properties required 
for spastin to regulate tubule fission are the same as those 
required to suppress protrusion formation, hinting that the 
two processes may be related [15]. Both SNX1 and SNX4 
tubules move along microtubules predominantly to the cell 
centre [15, 41]. From here, membrane may be delivered in 
a non-polarised fashion to the plasma membrane, either via 
the Golgi apparatus or perinuclear recycling endosomes. 
Thus, by inhibiting this process lack of spastin would be 
expected to inhibit generalised recycling (Fig. 8). In this 
sense, spastin would be antagonistic to the function of pro-
trudin in generalised recycling, which it has been proposed 
to inhibit by locking RAB11 in the inactive GDP-bound 
state. This model would also be consistent with our obser-
vation that either spastin isoform can support ER-mediated 
endosomal tubule fission [15]. We have previously sug-
gested that in the physiological situation, efficient spastin 
hexamer formation involves nucleation by M1-spastin at 
ER–endosome contacts involved in tubule fission, followed 
by recruitment of M87-spastin from a cytosolic pool to form 
functional spastin hexamers. This capacity of M1 spastin 
may perhaps be compensated for by direct recruitment of 
M87-spastin to endosomes by IST1 interaction.
In addition to affecting protrusion formation via effects 
on endosomal tubule fission, spastin could more directly 
influence protrudin-dependent microtubule-based polarised 
endosome motility. ER tubules are closely associated with 
microtubules [42], and the interaction and co-localisation 
observed between spastin and protrudin suggest that spastin 
would be positioned to sever or nick microtubules in close 
proximity to protrudin. Severing of these microtubules 
could counteract long-range KIF5-dependent movement 
of cargo towards the cell periphery, by physically break-
ing the microtubule rail or by facilitating dynein loading at 
new microtubule plus ends, so tipping the balance towards 
non-polarised minus-end-directed transport towards the 
centrosome. Spastin-induced nicking of microtubules could 
have a similar effect, as it introduces patches of new GTP-
tubulin into the microtubule lattice. In vitro such patches 
recruit plus-end proteins to the microtubule, which could 
enhance dynein loading and minus-end transport [6]. We 
have proposed a similar model of promoting plus-end dynein 
motor protein loading to explain how spastin drives fission 
of endosomal tubules from the endosomal body, which is 
known to involve a pulling force by dynein [15]. Finally, 
the physiological consequences of spastin-induced micro-
tubule nicking are not yet known, but if this were to lead 
to alterations in tubulin post-translational modification, it 
could conceivably have effects on MT-dependent motility 
of endocytic organelles, as exemplified by the observation 
that lysosomal transport stalls on patches of detyrosinated 
tubulin [43]. Interestingly, the protrusions that developed in 
cells lacking spastin were enriched for acetylated tubulin, a 
Fig. 6  Spastin depletion causes polarised distribution of BMPRII. 
a–d Wild-type HeLa cells (a, c) or HeLa cells staby expressing myc-
BMPRII (b, d) were mock-transfected (a, b) or subject to spastin 
KD by siRNA transfection (c, d), then labelled for the proteins indi-
cated. The panels in the second and fourth rows show higher magni-
fication views of the boxed regions in the panels above and arrows 
show regions of colocalisation. e HeLa cells stably expressing myc-
BMPRII were subject to spastin KD by siRNA transfection, then 
labelled for the proteins indicated. The lower panels are higher mag-
nification views of the boxed protrusion region in the upper panels. 
Arrows indicate regions of co-localisation. f Colocalisation between 
BMPRII versus KIF5 or acetylated tubulin was measured in HeLa 
cells stably expressing myc-BMPRII and treated with mock siRNA 
transfection, or spastin siRNA transfection. At least 13 cells quanti-
fied in each condition. P values generated by unpaired t tests. Scale 
bars = 20 μm
◂
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Fig. 7  BMPRII shows a polar-
ised distribution in primary 
cells from  spastinN384K/N384K 
mice. a MEFs from mice 
with the genotypes indicated 
were fixed and labelled for 
endogenous BMPRII and 
acetylated tubulin. The second, 
fourth and sixth panels show 
higher magnification views 
of the boxed areas indicated 
in the panels above. BMPRII 
concentrates at the tip of the 
cellular protrusions that develop 
in cells from the  spastinN384K/
N384K mice. Scale bars in rows 
1, 3 and 5 = 100 μm, in 2, 4 and 
6 = 20 μm
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marker of long-lived microtubules that are associated with 
long-range transport.
It is clear from our work that regulation of spastin’s 
activity could provide an important cellular switch between 
generalised and polarised membrane traffic. In this regard, 
we have also discovered a novel role for the ESCRT-III-
associated proteins IST1 and CHMP1B in inhibiting protru-
sion formation, via their interaction with spastin. Although 
the steady-state localisation of CHMP1B is not known 
(due to lack of suitable antibodies), at steady state, IST1 
mainly localises to a subdomain of the early sorting endo-
somal compartment. Thus, as the endosome matures to the 
RAB7-positive late endosome, removal of IST1 could act 
as a temporal switch to reduce spastin-mediated endosomal 
tubule fission, thereby inhibiting generalised recycling and 
promoting protrudin-dependent endosomal motility. What 
Fig. 8  Schematic diagram of possible roles of spastin in generalised 
versus polarised membrane traffic. The cartoon on the left shows 
membrane traffic pathways in a cell without a protrusion, in the pres-
ence of functional spastin. Membrane that traffics to the cell centre 
in endosomal tubules (a process that requires spastin [15, 17]) can be 
redistributed from there to anywhere on the plasma membrane (PM), 
i.e., in a non-polarised fashion, because of the close localisation of 
the Golgi apparatus and perinuclear recycling compartment (PNREC) 
to the microtubule organising centre (MTOC). Endosomes are held in 
position by a balance between the activity of plus-end (+) and minus-
end-directed motor proteins. The cartoon on the right shows the 
effects of absence of functional spastin, and how this might lead to 
protrusion formation. Firstly, this causes inefficient endosomal tubule 
fission (1). This would be expected to reduce membrane delivery to 
the Golgi apparatus or PNREC (2), with consequent reductions in 
non-polarised, generalised membrane delivery to the plasma mem-
brane (3). Thus, spastin would tend to switch off generalised recy-
cling. In cells lacking spastin, the protrusions are protrudin (PTN) 
and KIF5-dependent, implying increased KIF5-dependent traffic of 
endosomes towards protrusions [19]. This may be aided by micro-
tubule alterations caused by lack of spastin, which could promote 
long-range plus-end-directed transport or inhibit dynein-dependent 
minus-end-directed transport of endosomes or endosomal tubules (4). 
Endosomal compartments are shown in yellow, the Golgi apparatus 
and post-Golgi carriers in blue, the PNREC and post-PNREC carriers 
in red
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properties of late endosomes determine whether they are 
subject to protrudin-dependent anterograde motility or to 
other anterograde or retrograde motility mechanisms are not 
fully understood, but at least involve membrane cholesterol, 
oxysterol or phospholipid composition [44].
As in protrudin over-expressing cells, cells depleted of 
spastin developed accumulations of endosomal markers at 
their tips, consistent with the model of increased anterograde 
KIF5-dependent vesicular traffic within the protrusions. Late 
endosomes at the tips of protrudin-induced protrusions fuse 
with the plasma membrane in a synaptotagmin-VIII-depend-
ent fashion, thus providing a mechanism by which mem-
brane receptor distribution could become polarised [19]. We 
examined whether spastin depletion affected the polarisation 
of BMP receptors, as this pathway has been implicated in 
HSP; cellular or in vivo animal models of multiple HSP 
subtypes have demonstrated upregulated BMP signalling, 
and axonal abnormalities in vertebrate and invertebrate HSP 
models have been rescued by inhibiting this upregulated sig-
nalling [22, 45–50]. In several cases, these BMP signalling 
abnormalities have been associated with abnormal endoso-
mal trafficking of the BMP type II receptor or its homo-
logues [22, 46, 49]. HeLa cells lacking spastin have upregu-
lated BMP signalling, but no alteration in the total cellular 
amount of the BMP receptor BMPRII [22]. However, we 
now show that spastin influences BMPRII distribution; in 
HeLa cells lacking spastin, BMPRII signal was concentrated 
within protrusions, where it co-localised with KIF5, and also 
on the plasma membrane surrounding the protrusions. The 
physiological relevance of this role of spastin in regulating 
BMPRII distribution was confirmed in primary embryonic 
fibroblasts derived from  spastinN384K/N384K mice, where 
BMPRII signal was also concentrated at the tips of protru-
sions. Thus, the protrusion phenotype associated with loss 
or dysfunction of spastin causes polarisation of a pathologi-
cally relevant membrane receptor. It will be interesting in 
the future to determine how spastin influences the role of 
protrudin in neurons, and the relevance of this function of 
the protein to the pathogenesis of HSP. This would involve 
thorough characterisation of neuronal and axonal pheno-
types in neurons lacking each or both proteins, as well as 
analysis of the corresponding effects on polarised endosomal 
membrane traffic, including of key receptors implicated in 
HSP such as BMPRII.
In summary, we have identified a physiologically relevant 
role for spastin in controlling the balance between general-
ised and polarised recycling. In addition, by showing that 
IST1 and CHMP1B are involved in this process, our work 
adds to the list of biological functions in which the ESCRT 
complexes have been implicated, which includes intralu-
menal vesicle formation at the late endosome, cytokinesis, 
nuclear envelope reformation, exocytosis and viral budding 
amongst others [51].
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